ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC30539-10mM(1mLinDMSO) |
|
1337482-17-3 |
Sofosbuvir impurity F
|
0 | C34H45FN4O13P2 | |
GC30538-5mg |
|
128322-44-1 |
MCLA hydrochloride
|
0 | C14H14ClN3O2 | |
GC30538-1mg |
|
128322-44-1 |
MCLA hydrochloride
|
0 | C14H14ClN3O2 | |
GC30537-100mg |
|
1314873-02-3 |
BPO-27 racemate
|
0 | C26H18BrN3O6 | |
GC30537-50mg |
|
1314873-02-3 |
BPO-27 racemate
|
0 | C26H18BrN3O6 | |
GC30537-10mg |
|
1314873-02-3 |
BPO-27 racemate
|
0 | C26H18BrN3O6 | |
GC30537-5mg |
|
1314873-02-3 |
BPO-27 racemate
|
0 | C26H18BrN3O6 | |
GC30537-1mg |
|
1314873-02-3 |
BPO-27 racemate
|
0 | C26H18BrN3O6 | |
GC30537-10mM(1mLinDMSO) |
|
1314873-02-3 |
BPO-27 racemate
|
0 | C26H18BrN3O6 | |
GC30536-100mg |
|
3625-57-8 |
Nile Blue A sulfate (Nile blue sulfate)
|
0 | C20H20N3O3S0.5 | |
GC30536-10mM(1mLinDMSO) |
|
3625-57-8 |
Nile Blue A sulfate (Nile blue sulfate)
|
0 | C20H20N3O3S0.5 | |
GC30535-10mg |
|
918629-48-8 |
Transdermal Peptide (TD 1 (peptide))
|
0 | C40H66N14O16S2 | |
GC30535-5mg |
|
918629-48-8 |
Transdermal Peptide (TD 1 (peptide))
|
0 | C40H66N14O16S2 | |
GC30535-1mg |
|
918629-48-8 |
Transdermal Peptide (TD 1 (peptide))
|
0 | C40H66N14O16S2 | |
GC30533-5mg |
|
1496552-28-3 |
Sofosbuvir impurity C
|
0 | C22H29FN3O9P | |
GC30533-1mg |
|
1496552-28-3 |
Sofosbuvir impurity C
|
0 | C22H29FN3O9P | |
GC30533-10mM(1mLinDMSO) |
|
1496552-28-3 |
Sofosbuvir impurity C
|
0 | C22H29FN3O9P | |
GC30532-100mg |
|
99105-77-8 |
Sulcotrione
|
0 | C14H13ClO5S | |
GC30532-50mg |
|
99105-77-8 |
Sulcotrione
|
0 | C14H13ClO5S | |
GC30532-10mM(1mLinDMSO) |
|
99105-77-8 |
Sulcotrione
|
0 | C14H13ClO5S | |